secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2024-04-24T23:59:59+00:00
Accession:  0001356576-24-000022
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus to report Q1 2024 results after market close on May 8, 2024
--------------------------------------------------------------------

- Q1 2024 financial and business results will be released after market close on Wednesday, May 8, 2024.
- Conference call and webcast scheduled for 4:30 p.m. ET on May 8, 2024, hosted by CEO Jack Khattar and CFO Tim Dec.
- No preliminary financial data or guidance was provided in the announcement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000022/0001356576-24-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000022/supn-20240424.htm
  HTML page:      https://secwatch.observer/filing/0001356576-24-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer